We are live on ! Find out more
TECH icon

Bio-Techne

556 hedge funds and large institutions have $16.2B invested in Bio-Techne in 2022 Q1 according to their latest regulatory filings, with 65 funds opening new positions, 199 increasing their positions, 209 reducing their positions, and 76 closing their positions.

New
Increased
Maintained
Reduced
Closed

269% more call options, than puts

Call options by funds: $30.2M | Put options by funds: $8.18M

8.03% more ownership

Funds ownership: 376.15%384.18% (+8%)

5% less repeat investments, than reductions

Existing positions increased: 199 | Existing positions reduced: 209

3% less funds holding

Funds holding: 575556 (-19)

14% less first-time investments, than exits

New positions opened: 65 | Existing positions closed: 76

15% less capital invested

Capital invested by funds: $19.1B → $16.2B (-$2.9B)

20% less funds holding in top 10

Funds holding in top 10: 1512 (-3)

Holders
556
Holders Change
-19
Holders Change %
-3.3%
% of All Funds
8.77%
Holding in Top 10
12
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-20%
% of All Funds
0.19%
New
65
Increased
199
Reduced
209
Closed
76
Calls
$30.2M
Puts
$8.18M
Net Calls
+$22M
Net Calls Change
+$14.6M
Name Holding Trade Value Shares
Change
Change in
Stake
American Century Companies
26
American Century Companies
Missouri
$146M -$10.9M -105,216 -7%
Fidelity Investments
27
Fidelity Investments
Massachusetts
$143M +$33.8M +327,888 +33%
Charles Schwab
28
Charles Schwab
California
$138M +$4.44M +43,060 +3%
Franklin Resources
29
Franklin Resources
California
$126M -$52.3M -506,948 -30%
Mackenzie Financial
30
Mackenzie Financial
Ontario, Canada
$124M +$118M +1,138,964 +11,268%
Marshall Wace
31
Marshall Wace
United Kingdom
$121M -$125M -1,206,872 -52%
Thrivent Financial for Lutherans
32
Thrivent Financial for Lutherans
Minnesota
$121M +$13.3M +129,364 +13%
Janus Henderson Group
33
Janus Henderson Group
United Kingdom
$119M -$29.9M -289,712 -21%
Legal & General Group
34
Legal & General Group
United Kingdom
$118M +$2.81M +27,232 +3%
T. Rowe Price Associates
35
T. Rowe Price Associates
Maryland
$112M -$4.37M -42,344 -4%
GCM
36
Geneva Capital Management
Wisconsin
$112M -$320K -3,100 -0.3%
Sumitomo Mitsui Trust Group
37
Sumitomo Mitsui Trust Group
Japan
$102M -$10.3M -100,056 -10%
SEI Investments
38
SEI Investments
Pennsylvania
$101M +$1.86M +18,056 +2%
RP
39
Riverbridge Partners
Minnesota
$100M -$1.18M -11,424 -1%
SBH
40
Segall Bryant & Hamill
Illinois
$97.7M +$1.71M +16,580 +2%
Assenagon Asset Management
41
Assenagon Asset Management
Luxembourg
$96.8M +$90.3M +875,536 +4,682%
AIM
42
Artemis Investment Management
United Kingdom
$92.3M -$43.3M -419,800 -33%
ClearBridge Investments
43
ClearBridge Investments
New York
$89.6M -$449K -4,348 -0.5%
ACM
44
American Capital Management
New York
$83.5M +$1.23M +11,968 +2%
Bank of America
45
Bank of America
North Carolina
$79M +$16.5M +160,160 +28%
VOYA Investment Management
46
VOYA Investment Management
Georgia
$75.7M +$25.5M +246,696 +54%
First Trust Advisors
47
First Trust Advisors
Illinois
$75.2M -$7.35M -71,224 -9%
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$75.1M +$669K +6,480 +0.9%
Swiss National Bank
49
Swiss National Bank
Switzerland
$73.7M +$8.91M +86,400 +15%
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
$73.5M +$76.3K +740 +0.1%

TECH Hedge Fund Activity: Q1 2022 in Review

556 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q1 2022, worth a combined $16.2B — down 15% from $19.1B a quarter earlier.

Sellers outnumbered buyers: 76 funds closed out of TECH and 65 opened new positions — a net loss of 11 holders — while 209 trimmed existing stakes and 199 added.

The largest buyer was Select Equity Group, opening a new position worth an estimated $288M. The largest seller was Marshall Wace, cutting an estimated $125M.

  • 556 institutional investors held Bio-Techne (TECH) as of Q1 2022, down from 575 in Q4 2021.
  • Funds reported $16.2B of Bio-Techne stock for Q1 2022, down 15% quarter-over-quarter.
  • 65 funds opened new Bio-Techne positions in Q1 2022 and 76 closed out, a net change of -11 holders.
  • The largest Bio-Techne buyer in Q1 2022 was Select Equity Group, an estimated $288M added.
  • The largest Bio-Techne seller in Q1 2022 was Marshall Wace, an estimated $125M sold.

Based on aggregated 13F filings for Q1 2022.